Old Web
English
Sign In
Acemap
>
authorDetail
>
S Devereux
S Devereux
King's College
Chronic lymphocytic leukemia
Ibrutinib
Medicine
Internal medicine
Immunology
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
FIRST‐LINE TREATMENT WITH IBRUTINIB FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): 7‐YEAR RESULTS FROM RESONATE‐2
2021
Hematological Oncology
Steven Coutre
Paul M. Barr
Carolyn Owen
T. Robak
Alessandra Tedeschi
Osnat Bairey
Jan A. Burger
Peter Hillmen
S Devereux
Sebastian Grosicki
Helen McCarthy
Jian-yong Li
D. Simpson
Fritz Offner
Carol Moreno
S. Dai
A. Szöke
J. P. Dean
Thomas J. Kipps
Paolo Ghia
Show All
Source
Cite
Save
Citations (0)
FIVE-YEAR FOLLOW-UP OF FIRST-LINE IBRUTINIB FOR TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA//SMALL LYMPHOCYTIC LYMPHOMA
2019
Hematological Oncology
Alessandra Tedeschi
Jan A. Burger
Paul M. Barr
Tadeusz Robak
Carolyn Owen
Paolo Ghia
Osnat Bairey
Peter Hillmen
Steven Coutre
S Devereux
Sebastian Grosicki
Helen McCarthy
Jian-Yong Li
David M. Simpson
Fritz Offner
Carol Moreno
Sandra Dai
Indu D. Lal
J. P. Dean
Thomas J. Kipps
Show All
Source
Cite
Save
Citations (0)
The Bruton Tyrosine Kinase (Btk) Inhibitor ACP-196: Marked Activity in Relapsed/Refractory CLL with a Favorable Safety Profile
2015
Blood
John C. Byrd
William G. Wierda
Jeffrey A. Jones
Susan O'Brien
Jennifer R. Brown
Anna Schuh
Peter Hillmen
Deborah M. Stephens
Paolo Ghia
S Devereux
Jorge M. Chaves
Jacqueline C. Barrientos
Min-Hui Wang
Jane Huang
Todd Covey
Tasheda Navarro
Wayne Rothbaum
Raquel Izumi
Ahmed Hamdy
Richard R. Furman
Show All
Source
Cite
Save
Citations (2)
1